Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor. [electronic resource]
Producer: 19940324Description: 903-7 p. digitalISSN:- 0008-5472
- Carrier Proteins -- physiology
- Cell Division -- drug effects
- Child
- Colonic Neoplasms -- pathology
- Heat-Shock Proteins -- physiology
- Humans
- Immunosuppressive Agents -- pharmacology
- Polyenes -- pharmacology
- Receptor, IGF Type 1 -- physiology
- Rhabdomyosarcoma -- pathology
- Sirolimus
- Tacrolimus -- pharmacology
- Tacrolimus Binding Proteins
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.